Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pall, Georg
INNWOP1, NCT04875585 / 2020-004707-13: Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC	Recruiting	2	33	Europe	neoadjuvant therapy with Pembrolizumab/Lenvatinib, Surgery, Adjuvant Treatment Phase	Medical University Innsbruck, Merck Sharp & Dohme LLC	Non Small Cell Lung Cancer	12/23	12/27
AGMT_LungCA-Reg, NCT04654364: Lung Cancer Registry	Recruiting	N/A	500	Europe		Arbeitsgemeinschaft medikamentoese Tumortherapie	Lung Cancer, NSCLC Stage IV, NSCLC, Stage III, SCLC, Extensive Stage, SCLC, Limited Stage	08/30	08/30